Full Text (PDF)
Review Article

Management of Type 2 Diabetes Mellitus in India

Murigendra B. Hiremath null, Murigendra B. Hiremath1 null, Ritesh Vernekar2 null, Dheeraj K. Veeranagoudar3 null

Author Information

Licence:




Indian Journal of Diabetes and Endocrinology 6(2):p 43-47, July - Dec 2024. | DOI: n.a

How Cite This Article:

Murigendra B. Hiremath, Ritesh Vernekar, Dheeraj K. Veeranagoudar. Management of Type 2 Diabetes Mellitus in India. Ind Jl of Diabetes and Endo. 2024;6(2): 43–47.
 


Timeline

Received : July 15, 2024         Accepted : July 31, 2024          Published : August 12, 2024

Abstract

Type 2 Diabetes Mellitus (T2DM) poses a significant public health challenge in India, with projections indicating an increase from 77 million cases in 2019 to 134 million by 2045. This review article examines recent advancements in T2DM management, guided by the Indian Council of Medical Research (ICMR) and International Diabetes Federation (IDF) guidelines, while also highlighting the contributions of Indian diabetologists. The ICMR has established a comprehensive framework emphasizing early diagnosis, lifestyle modifications, and proactive management of complications tailored to the Indian population’s unique needs. Key recommendations include regular screening of high-risk individuals, a balanced diet rich in fiber and lean proteins, and regular physical activity, including yoga. Pharmacological treatments range from metformin to newer agents like SGLT2 inhibitors and GLP-1 receptor agonists. Continuous monitoring for diabetes-related complications is crucial for reducing morbidity and mortality associated with T2DM.The IDF guidelines adapt to the Indian context by focusing on cost-effective strategies and culturally relevant lifestyle interventions. These guidelines advocate for personalized treatment plans and the integration of technological advancements such as continuous glucose monitoring (CGM) to enhance patient engagement. Contributions from Indian diabetologists emphasize culturally appropriate dietary guidelines, the role of yoga in managing diabetes, and community-based approaches that address social determinants of health. Moreover, traditional practices rooted in Ayurveda and holistic approaches continue to play a vital role in diabetes management. This review underscores the importance of combining modern medical practices with traditional methods to provide a comprehensive strategy for T2DM management in India. Future directions include a focus on personalized medicine and digital health technologies, which promise to enhance patient outcomes through tailored interventions.
 


References

No records found.


Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

Provide information related to the Ethics Committee approval with approval number OR write This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

The authors report no conflicts of interest in this work.


About this article


Cite this article

Murigendra B. Hiremath, Ritesh Vernekar, Dheeraj K. Veeranagoudar. Management of Type 2 Diabetes Mellitus in India. Ind Jl of Diabetes and Endo. 2024;6(2): 43–47.
 


Licence:




Received Accepted Published
July 15, 2024 July 31, 2024 August 12, 2024

DOI: n.a

Keywords

Type 2 Diabetes Mellitus • ICMR guidelines • IDF guidelines • lifestyle modifications • Pharmacological treatments • Diabetes management

Article Level Metrics

Last Updated

Tuesday 07 July 2026, 06:07:22 (IST)


593

Accesses

7
125
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received July 15, 2024
Accepted July 31, 2024
Published August 12, 2024

licence



Access this article



Share